Edwards Lifesciences, headquartered in Irvine, California, operates in over 25 countries and holds a global leadership position in the field of heart valves and hemodynamic monitoring. The company's products and technologies are focused on treating advanced cardiovascular diseases.

Clinicians use Edwards Lifesciences' products to address structural heart disease in patients and provide critical care to intensive care patients edward valve. These products are widely utilized in more than 100 countries and encompass transcatheter heart valves, transcatheter repair products, heart valve repair and replacement technologies, and hemodynamic monitoring systems.

The company's patient-centric, innovative technologies such as Transcatheter heart valves, Critical care technologies, Surgical valve technologies, and Transcatheter mitral and tricuspid therapies aim to enhance patient outcomes and offer treatment options for various heart conditions.

Edwards Lifesciences is recognized as a leading company in the industry, renowned for its dedication to innovation and the delivery of advanced cardiovascular technologies to improve patient care globally. Healthcare professionals employ the company's products to treat patients with structural heart disease and in critical care settings.

One of their notable medical device types is Transcatheter Aortic Valve Implantation (TAVI/TAVR), a minimally invasive procedure used to address aortic stenosis. During TAVI, a new valve is implanted over the existing valve, eliminating the need for open-heart surgery. This procedure is recommended for patients at high or intermediate risk for traditional surgery or for those unsuitable for surgery due to other medical conditions. TAVI offers several advantages, including minimized invasiveness, quicker recovery times, and reduced risks of complications.

Edwards Lifesciences offers a range of medical devices, including SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN XT, for transcatheter aortic valve replacement. These devices are designed to improve the quality of life for patients suffering from severe aortic stenosis and offer effective alternatives to open-heart surgery.